Anxiolytic agents with reduced sedative and ataxic effects
US7119196B2 · kind B2 · utility
9Cited by
4References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 28, 2003 |
| Grant date | Oct 10, 2006 |
| Priority date | — |
| Expiry date | Oct 12, 2023 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D519/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Orally active benzodiazepine derivatives and their salts are disclosed. These compounds and their salts have anxiolytic and anticonvulsant activity with reduced sedative/hypnotic/muscle relaxant/ataxic effects.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.